XML 159 R118.htm IDEA: XBRL DOCUMENT v3.25.0.1
Kenvue separation and discontinued operations - Details (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
May 17, 2024
May 15, 2024
Aug. 23, 2023
May 08, 2023
Dec. 29, 2024
Dec. 31, 2023
Jan. 01, 2023
Jan. 02, 2022
Jul. 02, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Commercial paper   $ 3,600              
Proceeds from issuance of commercial paper   $ 3,600              
Debt for equity exchange, shares exchanged (in shares) 182,329,550                
Loss on shares exchanged $ 400                
Common stock, par value per share (in usd per share)         $ 1.00 $ 1.00      
Proceeds from Kenvue initial public offering         $ 0 $ 4,241 $ 0    
Realized gain (loss) on investment       $ 2,500          
Common stock received in exchange offer     $ 31,400            
Accumulated other comprehensive loss         11,741 12,527      
Transition service agreement, term     24 months            
Separation costs incurred         145 $ 986   $ 1,089  
Incremental tax cost             $ 500    
Minimum                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Transition manufacturing agreement, term     3 months            
Maximum                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Transition manufacturing agreement, term     5 years            
Consumer Health Business                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Net assets divested     $ 11,600            
Accumulated other comprehensive loss     4,300            
Decrease in noncontrolling interest     1,200            
Noncash gain on exchange offer     $ 21,000            
Kenvue Inc.                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Split-off percentage     80.10%            
Kenvue Inc.                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Stock issued in exchange offer (in shares)     190,955,436            
Kenvue Inc.                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Common stock, par value per share (in usd per share)       $ 0.01          
Sale of stock (in USD per share)       $ 22.00          
Stock issued in exchange offer (in shares)     1,533,830,450            
Johnson & Johnson | Kenvue Inc.                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Percentage ownership after transaction       89.60%          
Common stock, value                 $ 1,300
Percentage ownership after transaction     9.50%            
Equity securities, fair market value     $ 4,300   $ 400        
Johnson & Johnson | Kenvue Inc. | Consumer Health Business                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Noncash gain on exchange offer     $ 2,800            
IPO | Kenvue Inc.                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares)       198,734,444          
Proceeds from Kenvue initial public offering       $ 4,200